2000
March: Paracel acquired by Celera Genomics (deal worth $283M)
August: Oxford Molecular acquired by Pharmacopeia (deal worth $27M)
September: Neomorphic acquired by Affymetrix (deal worth $70M)
October: Empaheon acquired by eBioinformatics (deal worth $11M)
December: Proteome acquired by Incyte (deal worth $77M)
2001
May: Rosetta Inpharmatics acquired by Merck (deal worth $620M)
July: Synomics acquired by Accelrys (deal worth $4M)
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
